Systemic Inflammation During the First Postnatal Month and the Risk of Attention Deficit Hyperactivity Disorder Characteristics Among 10 Year-old Children Born Extremely Preterm

Overview

Journal J Neuroimmune Pharmacol

Specialties Allergy & Immunology
Neurology
Pharmacology

Date 2017 Apr 14

PMID 28405874

Citations 39

Authors

Elizabeth N Allred

Olaf Dammann

Raina N Fichorova

Stephen R Hooper

Scott J Hunter

Robert M Joseph

Karl Kuban

Alan Leviton

Thomas Michael OShea

Megan N Scott

Affiliations

Soon will be listed here.

Abstract

Although multiple sources link inflammation with attention difficulties, the only human study that evaluated the relationship between systemic inflammation and attention problems assessed attention at age 2 years. Parent and/or teacher completion of the Childhood Symptom Inventory-4 (CSI-4) provided information about characteristics that screen for attention deficit hyperactive disorder (ADHD) among 793 10-year-old children born before the 28th week of gestation who had an IQ ≥ 70. The concentrations of 27 proteins in blood spots obtained during the first postnatal month were measured. 151 children with ADHD behaviors were identified by parent report, while 128 children were identified by teacher report. Top-quartile concentrations of IL-6R, TNF-α, IL-8, VEGF, VEFG-R1, and VEGF-R2 on multiple days were associated with increased risk of ADHD symptoms as assessed by a teacher. Some of this increased risk was modulated by top-quartile concentrations of IL-6R, RANTES, EPO, NT-4, BDNF, bFGF, IGF-1, PIGF, Ang-1, and Ang-2. Systemic inflammation during the first postnatal month among children born extremely preterm appears to increase the risk of teacher-identified ADHD characteristics, and high concentrations of proteins with neurotrophic properties appear capable of modulating this increased risk.

Citing Articles

Metabolomic Insights into Attention Deficit Hyperactivity Disorder: A Scoping Review.

Munoz-Zabaleta M, Garzon Rodriguez N, Diaz-Barrera L, Quiroz-Padilla M Metabolites. 2025; 15(2).

PMID: 39997758 PMC: 11857725. DOI: 10.3390/metabo15020133.

Computational Analysis and Experimental Data Exploring the Role of Hesperetin in Ameliorating ADHD and SIRT1/Nrf2/Keap1/OH-1 Signaling.

Mokhtar H, Abd El-Fadeal N, El-Sayed R, Hegazy A, El-Kherbetawy M, Hamad A Int J Mol Sci. 2024; 25(17).

PMID: 39273230 PMC: 11395673. DOI: 10.3390/ijms25179284.

Differences in the Interleukin Profiles in Inattentive ADHD Prepubertal Children Are Probably Related to Conduct Disorder Comorbidity.

Gonzalez-Villen R, Fernandez-Lopez M, Checa-Ros A, Tortosa-Pinto P, Aguado-Rivas R, Garre-Morata L Biomedicines. 2024; 12(8).

PMID: 39200282 PMC: 11351999. DOI: 10.3390/biomedicines12081818.

Epigenetic scores derived in saliva are associated with gestational age at birth.

Mckinnon K, Conole E, Vaher K, Hillary R, Gadd D, Binkowska J Clin Epigenetics. 2024; 16(1):84.

PMID: 38951914 PMC: 11218140. DOI: 10.1186/s13148-024-01701-2.

Chronic Pain and Psychiatric Conditions.

Johnston K, Huckins L Complex Psychiatry. 2023; 9(1-4):24-43.

PMID: 37034825 PMC: 10080192. DOI: 10.1159/000527041.

References

van Ewijk H, Heslenfeld D, Zwiers M, Buitelaar J, Oosterlaan J . Diffusion tensor imaging in attention deficit/hyperactivity disorder: a systematic review and meta-analysis. Neurosci Biobehav Rev. 2012; 36(4):1093-106. DOI: 10.1016/j.neubiorev.2012.01.003. View

Chang L, Wang M, Tsai P . Diagnostic Accuracy of Rating Scales for Attention-Deficit/Hyperactivity Disorder: A Meta-analysis. Pediatrics. 2016; 137(3):e20152749. DOI: 10.1542/peds.2015-2749. View

Oliveira S, Pillat M, Cheffer A, Lameu C, Schwindt T, Ulrich H . Functions of neurotrophins and growth factors in neurogenesis and brain repair. Cytometry A. 2012; 83(1):76-89. DOI: 10.1002/cyto.a.22161. View

Hecht J, Fichorova R, Tang V, Allred E, McElrath T, Leviton A . Relationship Between Neonatal Blood Protein Concentrations and Placenta Histologic Characteristics in Extremely Low GA Newborns. Pediatr Res. 2010; 69(1):68-73. PMC: 3066075. DOI: 10.1203/PDR.0b013e3181fed334. View

Brines M, Ghezzi P, Keenan S, Agnello D, De Lanerolle N, Cerami C . Erythropoietin crosses the blood-brain barrier to protect against experimental brain injury. Proc Natl Acad Sci U S A. 2000; 97(19):10526-31. PMC: 27058. DOI: 10.1073/pnas.97.19.10526. View

Bernfeld J . ADHD and factor analysis: are there really three distinct subtypes of ADHD?. Appl Neuropsychol Child. 2013; 1(2):100-4. DOI: 10.1080/21622965.2012.699421. View

Sriram K, OCallaghan J . Divergent roles for tumor necrosis factor-alpha in the brain. J Neuroimmune Pharmacol. 2007; 2(2):140-53. DOI: 10.1007/s11481-007-9070-6. View

Fichorova R, Onderdonk A, Yamamoto H, Delaney M, DuBois A, Allred E . Maternal microbe-specific modulation of inflammatory response in extremely low-gestational-age newborns. mBio. 2011; 2(1):e00280-10. PMC: 3025357. DOI: 10.1128/mBio.00280-10. View

Leviton A, Allred E, Fichorova R, Kuban K, OShea T, Dammann O . Antecedents of inflammation biomarkers in preterm newborns on days 21 and 28. Acta Paediatr. 2015; 105(3):274-80. PMC: 4747803. DOI: 10.1111/apa.13286. View

10.

Tjwa M, Luttun A, Autiero M, Carmeliet P . VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis. Cell Tissue Res. 2003; 314(1):5-14. DOI: 10.1007/s00441-003-0776-3. View

11.

Sun Y, Jin K, Xie L, Childs J, Mao X, Logvinova A . VEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia. J Clin Invest. 2003; 111(12):1843-51. PMC: 161428. DOI: 10.1172/JCI17977. View

12.

Castaneda-Arellano R, Beas-Zarate C, Feria-Velasco A, Bitar-Alatorre E, Rivera-Cervantes M . From neurogenesis to neuroprotection in the epilepsy: signalling by erythropoietin. Front Biosci (Landmark Ed). 2014; 19(8):1445-55. DOI: 10.2741/4295. View

13.

Wiseman S, Marlborough F, Doubal F, Webb D, Wardlaw J . Blood markers of coagulation, fibrinolysis, endothelial dysfunction and inflammation in lacunar stroke versus non-lacunar stroke and non-stroke: systematic review and meta-analysis. Cerebrovasc Dis. 2014; 37(1):64-75. DOI: 10.1159/000356789. View

14.

Hsiao E, Patterson P . Placental regulation of maternal-fetal interactions and brain development. Dev Neurobiol. 2012; 72(10):1317-26. DOI: 10.1002/dneu.22045. View

15.

van Tilborg E, Heijnen C, Benders M, van Bel F, Fleiss B, Gressens P . Impaired oligodendrocyte maturation in preterm infants: Potential therapeutic targets. Prog Neurobiol. 2015; 136:28-49. DOI: 10.1016/j.pneurobio.2015.11.002. View

16.

Chew L, DeBoy C . Pharmacological approaches to intervention in hypomyelinating and demyelinating white matter pathology. Neuropharmacology. 2015; 110(Pt B):605-625. PMC: 4690794. DOI: 10.1016/j.neuropharm.2015.06.008. View

17.

Islamov R, Chintalgattu V, Pak E, Katwa L, Murashov A . Induction of VEGF and its Flt-1 receptor after sciatic nerve crush injury. Neuroreport. 2004; 15(13):2117-21. DOI: 10.1097/00001756-200409150-00024. View

18.

Zhao Y, Forst C, Sayegh C, Wang I, Yang X, Zhang B . Molecular and genetic inflammation networks in major human diseases. Mol Biosyst. 2016; 12(8):2318-41. PMC: 4955784. DOI: 10.1039/c6mb00240d. View

19.

Zacchigna S, Lambrechts D, Carmeliet P . Neurovascular signalling defects in neurodegeneration. Nat Rev Neurosci. 2008; 9(3):169-81. DOI: 10.1038/nrn2336. View

20.

Power T, Mautone J, Manz P, Frye L, Blum N . Managing attention-deficit/hyperactivity disorder in primary care: a systematic analysis of roles and challenges. Pediatrics. 2008; 121(1):e65-72. DOI: 10.1542/peds.2007-0383. View